scholarly journals Opportunities for changes in the drug product design to enhance medication safety in older people: Evaluation of a national public portal for medication incidents

2020 ◽  
Vol 86 (10) ◽  
pp. 1946-1957 ◽  
Author(s):  
Fatma Karapinar‐Çarkit ◽  
Patricia M.L.A. Bemt ◽  
Mariam Sadik ◽  
Brigit Soest ◽  
Wilma Knol ◽  
...  
Keyword(s):  
Older People ◽  
Product Design ◽  
Medication Safety ◽  
Drug Product ◽  
Medication Incidents ◽  
Drug Product Design

scholarly journals Future Perspectives for Patient-Centric Pharmaceutical Drug Product Design with Regard to Solid Oral Dosage Forms

2019 ◽  
Vol 15 (3) ◽  
pp. 318-324 ◽  
Author(s):  
Nélio Drumond
Keyword(s):  
Product Design ◽  
Drug Product ◽  
Dosage Forms ◽  
Oral Dosage ◽  
Healthcare Provision ◽  
Pharmaceutical Drug ◽  
Solid Oral Dosage Forms ◽  
Oral Dosage Forms ◽  
Drug Product Design ◽  
Patient Centric

Abstract Purpose Additional costs for healthcare provision are expected for cases where the level of care provided is not according to the patient’s needs and demands. To address these issues and reduce costs, fundamental changes need to be made on how healthcare provision is administered to patients, which raises the opportunity for the implementation of patient-centric systems. Methods This review addresses the importance of implementing a patient-centric approach in current healthcare provision and emphasizes the need to adjust current development and business models for a successful application of patient-centric care. Results To increase awareness and avoid confusion, the purpose of patient-centric pharmaceutical drug product design is reviewed in detail and future market opportunities for patient-centric drug products are discussed. Conclusions With regard to solid oral dosage forms, the subject of patient-centric pharmaceutical drug product design will focus more on the customization of existing technologies (e.g., dosage form size reduction) to address the needs of specific patient populations such as pediatrics, geriatrics, dysphagia patients, or the cognitively impaired.

Anti-tuberculosis drug combination for controlled oral delivery using 3D printed compartmental dosage forms: From drug product design to in vivo testing

2017 ◽  
Vol 268 ◽  
pp. 40-48 ◽  
Author(s):  
Natalja Genina ◽  
Johan Peter Boetker ◽  
Stefano Colombo ◽  
Necati Harmankaya ◽  
Jukka Rantanen ◽  
...  
Keyword(s):  
Product Design ◽  
Drug Combination ◽  
Oral Delivery ◽  
Drug Product ◽  
Dosage Forms ◽  
In Vivo Testing ◽  
3D Printed ◽  
Drug Product Design
Sign in / Sign up

Export Citation Format

Share Document